PL4110288T3 - Kompozycje do stosowania miejscowego opracowane do utrzymywania i/lub przywracania integralności błon śluzowych i uszkodzonego naskórka - Google Patents

Kompozycje do stosowania miejscowego opracowane do utrzymywania i/lub przywracania integralności błon śluzowych i uszkodzonego naskórka

Info

Publication number
PL4110288T3
PL4110288T3 PL21714664.6T PL21714664T PL4110288T3 PL 4110288 T3 PL4110288 T3 PL 4110288T3 PL 21714664 T PL21714664 T PL 21714664T PL 4110288 T3 PL4110288 T3 PL 4110288T3
Authority
PL
Poland
Prior art keywords
mucosa
restore
integrity
maintain
topical compositions
Prior art date
Application number
PL21714664.6T
Other languages
English (en)
Inventor
Roberto Cerini
Original Assignee
Ricerfarma S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ricerfarma S.R.L. filed Critical Ricerfarma S.R.L.
Publication of PL4110288T3 publication Critical patent/PL4110288T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PL21714664.6T 2020-02-27 2021-02-25 Kompozycje do stosowania miejscowego opracowane do utrzymywania i/lub przywracania integralności błon śluzowych i uszkodzonego naskórka PL4110288T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102020000004069A IT202000004069A1 (it) 2020-02-27 2020-02-27 Composizioni topiche per il mantenimento e/o ripristino dell’integrità delle mucose e dell’epidermide lesa
PCT/IB2021/051573 WO2021171215A1 (en) 2020-02-27 2021-02-25 Topical compositions designed to maintain and/or restore the integrity of the mucosa and damaged epidermis

Publications (1)

Publication Number Publication Date
PL4110288T3 true PL4110288T3 (pl) 2024-07-08

Family

ID=70738958

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21714664.6T PL4110288T3 (pl) 2020-02-27 2021-02-25 Kompozycje do stosowania miejscowego opracowane do utrzymywania i/lub przywracania integralności błon śluzowych i uszkodzonego naskórka

Country Status (30)

Country Link
US (2) US20230114487A1 (pl)
EP (1) EP4110288B1 (pl)
JP (1) JP7713242B2 (pl)
KR (1) KR20220146582A (pl)
CN (1) CN115209873A (pl)
AU (1) AU2021225476B2 (pl)
BR (1) BR112022016597A2 (pl)
CA (1) CA3169514A1 (pl)
CL (1) CL2022002324A1 (pl)
CO (1) CO2022010763A2 (pl)
DK (1) DK4110288T3 (pl)
ES (1) ES2986010T3 (pl)
FI (1) FI4110288T3 (pl)
HR (1) HRP20240784T1 (pl)
HU (1) HUE066958T2 (pl)
IL (1) IL295822A (pl)
IT (1) IT202000004069A1 (pl)
LT (1) LT4110288T (pl)
MA (1) MA58793B1 (pl)
MX (1) MX428861B (pl)
MY (1) MY210387A (pl)
PE (1) PE20221833A1 (pl)
PH (1) PH12022552115A1 (pl)
PL (1) PL4110288T3 (pl)
PT (1) PT4110288T (pl)
RS (1) RS65451B1 (pl)
SI (1) SI4110288T1 (pl)
SM (1) SMT202400226T1 (pl)
WO (1) WO2021171215A1 (pl)
ZA (1) ZA202210572B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202400003238A1 (it) * 2024-02-15 2025-08-15 Ricerfarma Srl Compressa orale mucoadesiva per il trattamento sintomatico della xerostomia, delle afte e delle infiammazioni del cavo orale
ES3072372A1 (es) * 2024-12-27 2026-07-01 Laboratorios Vinas S A Composición galénica de uso tópico, método de preparación y uso de la misma para el tratamiento de trastornos vulvares

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH683671A5 (it) 1992-03-30 1994-04-29 Golgi Sa Uso topico di glicerofosfolipidi deacilati.
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti
DE102004002001A1 (de) * 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Mittel zur Behandlung von entzündlichen Erkrankungen
US20070196311A1 (en) * 2006-02-21 2007-08-23 Gross Dennis F Methods and kits for topical administration of hyaluronic acid
FR2946252B1 (fr) * 2009-06-08 2011-07-29 Fabre Pierre Dermo Cosmetique Bis esters d'acide gras insature sur l'acide ascorbique et leurs utilisations cosmetiques
IT1402907B1 (it) * 2010-11-30 2013-09-27 Ricerfarma Srl Composizioni topiche per mantenere o ripristinare l'integrita' delle mucose.

Also Published As

Publication number Publication date
CO2022010763A2 (es) 2022-08-19
RS65451B1 (sr) 2024-05-31
PT4110288T (pt) 2024-05-02
JP7713242B2 (ja) 2025-07-25
LT4110288T (lt) 2024-04-25
HUE066958T2 (hu) 2024-09-28
SMT202400226T1 (it) 2024-07-09
WO2021171215A1 (en) 2021-09-02
EP4110288A1 (en) 2023-01-04
US20240024352A1 (en) 2024-01-25
ZA202210572B (en) 2024-01-31
MX428861B (es) 2025-11-13
US20230114487A1 (en) 2023-04-13
MA58793B1 (fr) 2024-04-30
PE20221833A1 (es) 2022-11-29
US12251398B2 (en) 2025-03-18
KR20220146582A (ko) 2022-11-01
AU2021225476A1 (en) 2022-10-13
FI4110288T3 (fi) 2024-06-28
CN115209873A (zh) 2022-10-18
PH12022552115A1 (en) 2024-01-29
IL295822A (en) 2022-10-01
CL2022002324A1 (es) 2023-03-31
MY210387A (en) 2025-09-18
CA3169514A1 (en) 2021-09-02
HRP20240784T1 (hr) 2024-09-27
MX2022010645A (es) 2022-09-23
ES2986010T3 (es) 2024-11-08
IT202000004069A1 (it) 2021-08-27
DK4110288T3 (da) 2024-04-22
JP2023522295A (ja) 2023-05-30
AU2021225476B2 (en) 2026-07-16
SI4110288T1 (sl) 2024-05-31
EP4110288B1 (en) 2024-03-27
BR112022016597A2 (pt) 2023-04-04

Similar Documents

Publication Publication Date Title
IL299378A (en) Preparations and methods related to operable medical agents
SMT202400226T1 (it) Composizioni topiche per il mantenimento e/o il ripristino dell'integrita' delle mucose edell'epidermide lesa
WO2018136264A9 (en) Pyridine compounds as allosteric shp2 inhibitors
AR113901A1 (es) Uso tópico y entrega de microorganismos oxidantes de amoniaco
PL4132895T3 (pl) Kompozycja częściowo protonowanych alkanoloamin i zastosowanie w młynie
GB201206486D0 (en) Vesicular formulations and uses thereof
DK1988909T3 (da) Anvendelse af polyethylenglycol til inflammationsbeslægtede topiske lidelser eller sygdomme og sårheling
EP4301332A4 (en) TOPICAL COMPOSITION AND ITS USE
HK1252057A1 (zh) 新颖的使用方法和组合物
EP4452948A4 (en) Tetrahydrobenzazepinones and related analogues for the inhibition of YAP/TAZ-TEAD
PL4288025T3 (pl) Kompozycja oraz sposób nieterapeutycznego złuszczania naskórka
NZ706185A (en) Decubitus treatment system
PL4188420T3 (pl) Kompozycje i sposoby związane z leczeniem chorób
ZA202308258B (en) Compositions comprising naturally derived preservatives
WO2010121676A3 (de) Verwendung von glycyrrhetinsäure und/oder deren derivaten zur herstellung kosmetischer oder dermatologischer zubereitungen zur prophylaxe von schäden an der hauteigenen dna und/oder zur reparatur bereits eingetretener schäden an der hauteigenen dna
BR112017019365A2 (pt) composição cosmética redutora de aplicação tópica contendo queratina e enxofre
HK40117318A (en) Topical formulation for use in the treatment or prevention of itchy dry skin
WO2014197129A3 (en) Compositions and methods for treatment and management of pain
PL4117709T3 (pl) Kompozycje i sposoby związane z leczeniem chorób
IL305865A (en) Dermatological preparations and their uses
GB202316080D0 (en) Improvements in or relating to devices and methods
GB202003812D0 (en) Compositions and methods relating to the treatment of diseases
HK40038524A (en) Topical ointment formulations of pde-4 inhibitor and their use in treating skin conditions
CA3290113A1 (en) Ingestible formulations comprising methylliberine and one or more sugars and their use to treat the adverse effects of alcohol consumption
GB202112662D0 (en) Improvements in or relating to devices and methods